Integer (ITGR) Reports Next Week: Wall Street Expects Earnings Growth
https://www.zacks.com/stock/news/2223427/integer-itgr-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2223427
Feb 08, 2024 - Integer (ITGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Here's Why You Should Invest in Boston Scientific (BSX) Now
https://www.zacks.com/stock/news/2223513/here-s-why-you-should-invest-in-boston-scientific-bsx-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2223513
Feb 08, 2024 - Investors are optimistic about Boston Scientific (BSX) on strength across the target market and upbeat guidance.
0
Integer (ITGR) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
https://www.zacks.com/stock/news/2224651/integer-itgr-q4-earnings-on-the-horizon-analysts-insights-on-key-performance-measures?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224651
Feb 12, 2024 - Beyond analysts' top -and-bottom-line estimates for Integer (ITGR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
0
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2231789/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2231789
Feb 26, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Why Integer (ITGR) is a Top Growth Stock for the Long-Term
https://www.zacks.com/stock/news/2245447/why-integer-itgr-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2245447
Mar 25, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Reasons to Add ShockWave Medical (SWAV) to Your Portfolio Now
https://www.zacks.com/stock/news/2248484/reasons-to-add-shockwave-medical-swav-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2248484
Apr 01, 2024 - ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
0
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2248345/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2248345
Apr 01, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Why You Should Retain Integer Holdings (ITGR) Stock for Now
https://www.zacks.com/stock/news/2252801/why-you-should-retain-integer-holdings-itgr-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2252801
Apr 09, 2024 - Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.
0
ITGR vs. EW: Which Stock Should Value Investors Buy Now?
https://www.zacks.com/stock/news/2256237/itgr-vs-ew-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2256237
Apr 16, 2024 - ITGR vs. EW: Which Stock Is the Better Value Option?
0
Microbot Medical (MBOT) Files IDE to Start Human Clinical Study
https://www.zacks.com/stock/news/2222672/microbot-medical-mbot-files-ide-to-start-human-clinical-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2222672
Feb 07, 2024 - Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.
0
Pages: 12
Page 1